De Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 2005; 19: 2100-2110.
Neidle S. Parkinson GN. The structure of telomeric DNA. Curr Op Struct Biol 2003; 13: 275-283.
Benetti R. Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres. Nat Genet 2007; 39: 243-250.
Tang J. Histone deacetylases as targets for treatment of multiple diseases. Clin Sci 2013; 124: 651-662.
Palacios JA. SIRT1 contributes to telomere maintenance and augments global homologous recombination. J Cell Biol 2010; 191: 1299-1313.
Michishita E. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452: 492-496.
Michishita E. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 2009; 8: 2664-2666.
Woo HJ. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol 2007; 82: 77-84.
Peixoto P. HDAC5 is required for maintenance of pericentric heterochromatin, and controls cell-cycle progression and survival of human cancer cells. Cell Death Diff 2012; 19: 1239-1252.
Uziel O. Telomere shortening sensitizes cancer cells to selected cytotoxic agents: In vitro and in vivo studies and putative mechanisms. Plos One 2010; 5: 1-14.
Arturo Londoño-Vallejo J. Un Nobel centenaire célèbre télomères et télomérase. Med Sci (Paris) 2009; 25: 973-976.
Touzot F, Le Guen T, de Villartray JP, Révy P. Nouvelles formes de dyskératoses congénitales. Med Sci (Paris) 2012; 28: 618-624.